Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
- PMID: 34514078
- PMCID: PMC8421108
- DOI: 10.1016/j.ijcha.2021.100869
Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Dagan N., Barda N., Kepten E., Miron O., Perchik S., Katz M.A., Hernán M.A., Lipsitch M., Reis B., Balicer R.D. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N. Engl. J. Med. 2021;384(15):1412–1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24. PMID: 33626250; PMCID: PMC7944975. - DOI - PMC - PubMed
-
- Abu Mouch S., Roguin A., Hellou E., Ishai A., Shoshan U., Mahamid L., Zoabi M., Aisman M., Goldschmid N., Berar Yanay N. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021 doi: 10.1016/j.vaccine.2021.05.087. S0264-410X(21)00682-4. Epub ahead of print. PMID: 34092429; PMCID: PMC8162819. - DOI - PMC - PubMed
-
- Ammirati E., Cavalotti C., Milazzo A., Pedrotti P., Soriano F., Schroeder J.W., Morici N., Giannattasio C., Frigerio M., Metra M., Camici P.G., Oliva F. Temporal Relation Between Second Dose BNT162b2 mRNA Covid-19 Vaccine and Cardiac involvement in a Patient with Previous SARS-COV-2 Infection. Int. J. Cardiol. Heart Vasc. 2021:100778. doi: 10.1016/j.ijcha.2021.100778. Epub ahead of print. PMID: 33842684; PMCID: PMC8020086. - DOI - PMC - PubMed
-
- Larson K.F., Ammirati E., Adler E.D., Cooper L.T., Hong K.N., Saponara G., Couri D., Cereda A., Procopio A., Cavalotti C., Oliva F., Sanna T., Ciconte V.A., Onyango G., Holmes D.R., Jr., Borgeson D.D. Myocarditis after BNT162b2 and mRNA-1273 Vaccination. Circulation. 2021 doi: 10.1161/CIRCULATIONAHA.121.055913. Epub ahead of print. PMID: 34133884. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
